{
  "docId": "019dd923-622c-750b-8b9b-7e7228555e88",
  "docSlug": "36c903ba19aa",
  "documentTitle": "Allergan, Inc. (AGN)",
  "authorId": "01_Pershing_Square",
  "authorName": "William Ackman",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2014-04-22 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.70665085,
  "pageNumber": 36,
  "pageCount": 110,
  "prevPage": 35,
  "nextPage": 37,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "sparse",
  "nDataPoints": 1,
  "notes": null,
  "elementsJson": [
    "headline_text",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/36",
  "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-36",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.65,
        "x": 0.095,
        "y": 0.13
      },
      "kind": "list",
      "text": "Line extensions and re-formulations: Example: Acanya\nNew indications and strengths for existing drugs: Example: Retin-A Micro .08%\nNew branded generics: Example: 300 new product launches expected in 2014\nPrescription to OTC switches: Example: Bedoyecta\nHigh-probability development programs (Phase IIIs): Example: Luzu\nLow-risk New Chemical Entities (NCE's): Example: Jublia",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e07e88b7-dcec-45a8-b935-0ce0fb2f57ec",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.45,
        "x": 0.095,
        "y": 0.085
      },
      "kind": "title",
      "text": "Track Record of R&D Productivity",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77b85062-62d1-4824-aad6-12c3206d4c29",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "b45aed9f-2ff1-4d7c-a72b-b8193c307c58",
      "evidence": "The slide contains a list of bullet points describing Valeant's R&D productivity.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}